BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20380502)

  • 1. A qualitative study of illicit and non-prescribed drug use amongst people with psychotic disorders.
    Charles V; Weaver T
    J Ment Health; 2010 Feb; 19(1):99-106. PubMed ID: 20380502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons for substance use among people with psychotic disorders: method triangulation approach.
    Thornton LK; Baker AL; Johnson MP; Kay-Lambkin F; Lewin TJ
    Psychol Addict Behav; 2012 Jun; 26(2):279-88. PubMed ID: 22149956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for increased substance use in psychosis.
    Gregg L; Barrowclough C; Haddock G
    Clin Psychol Rev; 2007 May; 27(4):494-510. PubMed ID: 17240501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use in severe mental illness: self-medication and vulnerability factors.
    Bizzarri JV; Rucci P; Sbrana A; Miniati M; Raimondi F; Ravani L; Massei GJ; Milani F; Milianti M; Massei G; Gonnelli C; Cassano GB
    Psychiatry Res; 2009 Jan; 165(1-2):88-95. PubMed ID: 19054572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons for cannabis use in men with and without psychosis.
    Green B; Kavanagh DJ; Young RM
    Drug Alcohol Rev; 2004 Dec; 23(4):445-53. PubMed ID: 15763749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders.
    Dekker N; Linszen DH; De Haan L
    Psychopathology; 2009; 42(6):350-60. PubMed ID: 19752588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards understanding the self-perception of people with a psychotic illness who use illicit substances and have a history of disengagement from mental health services: qualitative research.
    Wagstaff C
    Int J Psychiatr Nurs Res; 2007 May; 12(3):1503-20. PubMed ID: 17682591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
    Møller T; Linaker OM
    Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reasons for substance use among people with mental disorders.
    Thornton LK; Baker AL; Lewin TJ; Kay-Lambkin FJ; Kavanagh D; Richmond R; Kelly B; Johnson MP
    Addict Behav; 2012 Apr; 37(4):427-34. PubMed ID: 22197045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team - final results.
    Agius M; Shah S; Ramkisson R; Murphy S; Zaman R
    Psychiatr Danub; 2007 Sep; 19(3):130-8. PubMed ID: 17914313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risky use and misuse of alcohol, drugs and cigarettes detected by screening questionnaires in a clinical psychosis unit.
    Cruce G; Nordström LG; Ojehagen A
    Nord J Psychiatry; 2007; 61(2):92-9. PubMed ID: 17454723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Models of co-occurring substance misuse and psychosis: are personality traits the missing link?
    Hides L; Lubman DI; Dawe S
    Drug Alcohol Rev; 2004 Dec; 23(4):425-32. PubMed ID: 15763747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Self medication by the adolescent].
    Jaquier F; Buclin T; Diezi J
    Schweiz Med Wochenschr; 1998 Feb; 128(6):203-7. PubMed ID: 9540142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication for psychosis--consumption and consequences: the second Australian national survey of psychosis.
    Waterreus A; Morgan VA; Castle D; Galletly C; Jablensky A; Di Prinzio P; Shah S
    Aust N Z J Psychiatry; 2012 Aug; 46(8):762-73. PubMed ID: 22689337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences of psychosis in borderline personality disorder: a qualitative analysis.
    Adams B; Sanders T
    J Ment Health; 2011 Aug; 20(4):381-91. PubMed ID: 21770785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories.
    Iyer SN; Boekestyn L; Cassidy CM; King S; Joober R; Malla AK
    Psychol Med; 2008 Aug; 38(8):1147-56. PubMed ID: 18366823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brief motivational intervention for substance misuse in recent-onset psychosis.
    Kavanagh DJ; Young R; White A; Saunders JB; Wallis J; Shockley N; Jenner L; Clair A
    Drug Alcohol Rev; 2004 Jun; 23(2):151-5. PubMed ID: 15370020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.